Could Viking Therapeutics Become the Next Novo Nordisk?
Why Is Viking Therapeutics, Inc. (VKTX) the Best Diabetes Stock to Buy Now?
Viking Therapeutics Insider Sold Shares Worth $1,195,736, According to a Recent SEC Filing
Director J Singleton Sells 20,786 Shares of Viking Therapeutics Inc (VKTX)
Deutsche Bank praises Eli Lilly and Co (LLY.US) as a "high-growth unicorn", with a target price skyrocketing to $1025.
Deutsche Bank has upgraded its rating on Eli Lilly and Co (LLY.US) from "hold" to "buy" with a target price increase from $725 to $1025.
Buy Russell 1000 Health Care Growth, Says Oppenheimer in Highlighting Top Sector Ideas
105535782 : ok